Author Correction: Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis

By afschroeder • February 6, 2026

Li S, Noor ZS, Zeng W, Stackpole ML, Ni X, Zhou Y, Yuan Z, Wong WH, Agopian VG, Dubinett SM, Alber F, Li W, Garon EB, Zhou XJ. Author Correction: Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis. Nat Commun. 2026 Feb 5;17(1):1388. doi: 10.1038/s41467-026-69268-5. Erratum for: Nat Commun. 2021 Jul 7;12(1):4172. doi: 10.1038/s41467-021-24457-2. PMID: 41644545.

Tags: Hematology/Oncology, Publications, Pulmonary, Critical Care & Sleep Medicine

Tamibarotene with venetoclax and azacitidine in RARA+ acute myeloid leukemia: results from the SY-1425-202 study

Cluzeau T, Borate U, McMahon C, Fenaux P, Heiblig M, Peterlin P, Ball B, Chantepie S, Eghtedar A, Kambhampati S, Solh M, Torregrosa-Diaz J, Braun[...]

Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles Safety-Net Health System: Tyrosine Kinase Inhibitor Treatment Patterns and Outcomes From 2015 to 2024

Zheng D, Nold T, Ramakrishnan N, Kim K, Tomassetti S. Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles[...]

Evolution and heterogeneity of lethal metastatic bladder cancer subtypes

Itagi P, Schuster SL, Arora S, Persse TW, Waters JA, Yang M, Min A, Chandra P, Adil M, Galipeau PC, Rudoy D, Kreitman AS, Lin[...]